We Are GridMarkets Pharma
GridMarkets is a unique, molecular simulation and screening platform built to accelerate drug discoveries easily at scale and on-demand.
We are on a mission to empower pharma leaders and computational chemists around the world with access to cost-efficient, pay-as-you-go, leading drug discovery software tools.
Over a decade ago in a Hong Kong coffee shop, entrepreneurs Mark Ross and Hakim Karim started a cloud and Grid-computing technology company called GridMarkets. Their focus was to remove access and cost barriers to secure, high performance compute resources for creative innovators like computational chemists and virtual effects artists.
GridMarkets Pharma is designed to eliminate the complexity and risk of running computationally demanding molecular simulation and screen workloads at scale. We also reduce overall run costs by removing the large up front expenses of traditional solutions. This gives pharma leaders of all sizes access to the cutting-edge technical resources to empower their success and growth.
Through our exclusive partnerships with respected organizations including Oracle, AWS, Chemical Computing Group and QuantumBio, we offer unparalleled access to software licenses and machines - with a simple push button workflow.
With offices in San Francisco, Philadelphia, Kuala Lumpur and Bangalore, GridMarkets is globally diverse with team members connected by our passion for creativity, collaboration and innovation. We strive to create a culture of inclusion, empowerment and equity for the good of our customers, community and team. We challenge the status quo, and respect and learn from each other's unique experiences to continually seek new ways to build, experiment, and create value.
Meet Our Team
Our Scientific Advisors
molecular simulation, drug discovery, quantumbio, amber, namd, gromacs, MOE, CCG, cloud, Oracle, OCI, AWS, drug discovery, bioinformatics, drug design, computer aided molecular design, crystallographers, software, protein, modeling, analysis, virtual screening, small molecules, HPC, high performance compute